Presentation of Antigen by Endothelial Cells and Chemoattraction Are Required for Homing of Insulin-specific CD8+ T Cells by Savinov, Alexei Y. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2003/03/643/14 $8.00
Volume 197, Number 5, March 3, 2003 643–656
http://www.jem.org/cgi/doi/10.1084/jem.20021378
 
643
 
Presentation of Antigen by Endothelial Cells and 
Chemoattraction Are Required for Homing of 
Insulin-speciﬁc CD8
 
 
 
 T Cells
 
Alexei Y. Savinov,
 
1 
 
F. Susan Wong,
 
2 
 
Austin C. Stonebraker,
 
1
 
and Alexander V. Chervonsky
 
1
 
1
 
The Jackson Laboratory, Bar Harbor, ME 04609
 
2
 
The Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, 
Bristol BS8 1TD, United Kingdom
 
Abstract
 
Activated insulin-specific CD8
 
 
 
 T cells (IS-CD8
 
 
 
 cells) home to the pancreas, destroy 
 
 
 
 cells,
and cause rapid diabetes upon transfer into diabetes-prone NOD mice. Surprisingly, they also
cause diabetes in mouse strains that are free of preexistent inflammation. Thus, we hypothe-
sized that islet-specific homing may be in part dependent on IS-CD8
 
 
 
 cells’ recognition of the
cognate major histocompatibility complex (MHC)/peptide complexes presented by pancreatic
endothelial cells, which acquire the antigen (insulin) from 
 
 
 
 cells. In fact, islet-specific homing
was abrogated in mice that lack MHC class I expression, or presentation of the specific peptide,
or have impaired insulin secretion. Moreover, we found that IS-CD8
 
 
 
 cells directly recognized
pancreatic endothelial cells in islet organ cultures. Triggering of IS-CD8
 
 
 
 cells’ T cell receptor
(TCR) led to activation of integrins expressed by these cells. In addition, chemokines, particu-
larly SLC (CCL21), were also required for IS-CD8
 
 
 
 cells’ adhesion to endothelial monolayers
and for successful homing in vivo. Thus, signaling through TCR and chemokine receptors
work in concert to assure firm adhesion of T cells to the pancreatic endothelium. The antigen
cross-presentation ability of endothelia may therefore contribute to the specificity of homing of
activated T lymphocytes to the tissues where antigens are generated by other cell types.
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Introduction
 
T cells cause autoimmune diabetes. For this process both
CD4
 
 
 
 and CD8
 
 
 
 cells are required (1–3). In NOD/LtJ
(NOD) mice, CD8
 
 
 
 cells are necessary for initiation of
spontaneous diabetes, as NOD mice lacking expression of
MHC class I are protected from the disease (4). Insulin-
specific CD8
 
 
 
 T cells found within the infiltrates in the
pancreata of prediabetic NOD mice (5) recognize a peptide
from insulin B chain amino acids 15–23 (InsB
 
15–23
 
)
 
*
 
 in the
context of the MHC class I molecule, H2-K
 
d
 
 and are po-
tent inducers of diabetes (6). However, in order to destroy
pancreatic islets, insulin-specific CD8
 
 
 
 T cells (IS-CD8
 
 
 
cells) must first home into the islets. T cells follow certain
rules when homing to the secondary lymphoid organs, spe-
cialized compartments such as intestinal epithelium and
skin, and also to sites of inflammation (7, 8). Inflammation
is undoubtedly a significant factor in lymphocyte homing,
as it stimulates leukocyte adhesion to vascular endothelium
(9). It is obviously very important to know whether hom-
ing of CD8
 
 
 
 T cells to the site of an immune response
against a pathogen is driven solely by nonspecific adhesion
mechanisms, or whether T cell receptor specificity contrib-
utes to the process. The same question can justly be asked
about T cells that mount autoimmune responses against or-
gan-specific self-antigens. It has been previously suggested
that the antigen-presenting function of endothelial cells
could contribute to lymphocyte homing (10, 11). We
found that IS-CD8
 
 
 
 cells were able to induce diabetes in
H2-K
 
d
 
–positive mouse strains other than NOD. This
suggested to us that preexistent inflammation in the pan-
creas is dispensable for the homing of the activated IS-CD8
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Abbreviations used in this paper:
 
 CFSE, carboxyfluorescein diacetate
succinimidyl ester; DiI, didodecyl-tetramethylindocarbocyanine per-
chlorate; FBN, fibronectin; GFP, green fluorescent protein; InsB
 
15-23
 
, in-
sulin B chain peptide amino acids 15-23; LLO
 
91-99
 
, listeriolysin peptide,
amino acids 91–99; IS-CD8
 
 
 
 cells, insulin-specific CD8
 
 
 
 T cells; PTx,
pertussis toxin.T
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cells. Thus, we sought to investigate whether cross-presen-
tation of the specific antigen by pancreatic endothelium is
one of the requirements for the homing of these cells into
the islets.
 
Materials and Methods
 
Mice.
 
C57BL/6J (B6), C57BL/6-TgN(ACTbEGFP)1Osb
(B6-GFP), NOD/LtJ (NOD), DBA/2J, BALB/cJ, (C3H/He-
JxDBA/2J) F1 (C3D2), (C57BL/6JxDBA/2J) F1 (B6D2),
NOD.129P2(B6)-B2m
 
tm1Unc
 
/J (NOD.
 
 
 
2m-KO), NOD.129S7
(B6)-Rag1
 
tm1Mom
 
 (NOD.Rag1-KO), NOD.B10Sn-
 
H2
 
b
 
,
NOD.NON-
 
H2
 
nb1
 
, B6.NOD
 
-D17Mit21-D17Mit10 (H2
 
g7
 
,
Idd1) (B6.NOD-
 
H2
 
g7
 
), and B10.BR-
 
H2
 
k
 
 H2-T18
 
a
 
/SgSnJ
(B10.BR) mice were obtained from The Jackson Laboratory.
C57BL/6-
 
Ins2
 
Akita
 
 (B6
 
Akita/
 
 
 
) mice and B6
 
Akita/
 
 
 
 backcrossed to
NOD for N2–3 (NOD.B6
 
Akita/
 
 
 
) were a gift of Dr. Leonard
Shultz (The Jackson Laboratory, Bar Harbor, ME). All animals
were housed in a specific pathogen-free research facility.
 
CD8
 
 
 
 T Cell Clones.
 
Insulin-specific, K
 
d
 
-restricted T cells,
IS-CD8
 
 
 
 cells of the TGNFC8 clone (5) were maintained in
vitro as described previously (6) in Click’s medium (Irvine Scien-
tific) supplemented with 5% FCS (Sigma-Aldrich), 2 
 
 
 
 10
 
 
 
5
 
 M
 
 
 
2-mercaptoethanol (Bio-Rad Laboratories), 20 mM penicillin-
streptomycin mixture (Life Technologies), 3 mg/ml 
 
l
 
-glutamine
(Life Technologies), and 5 U/ml mouse recombinant IL-2. Cells
were stimulated every 3 wk by irradiated (2,000 Rad) NOD-
derived pancreatic islets, or by NOD splenocytes loaded
with 10 
 
 
 
g/ml of the synthetic insulin B chain (InsB
 
15–23
 
,
LYLVCGERG) peptide produced by Research Genetics. Pan-
creatic islets were isolated by a collagenase digestion method, and
hand-picked in Hanks’ solution (Life Technologies) after purifi-
cation on a Histopaque 1119 (Sigma-Aldrich) gradient (12). Con-
trol D
 
b
 
-restricted T cell clones LPa/2R-1 and B/L specific for the
peptides derived from minor histocompatibility antigen H3a (al-
leles H3a
 
a
 
 and H3a
 
b
 
, respectively; reference 13) were provided by
Dr. Derry Roopenian (The Jackson Laboratory). K
 
d
 
-restricted
anti-listeriolysin peptide (LLO
 
91–99
 
) CD8
 
 
 
 T cell clone L12.3 (14)
was a gift from Dr. Eric Pamer (Memorial Sloan-Kettering Can-
cer Center, New York, NY).
 
Induction of Diabetes.
 
IS-CD8
 
 
 
 cells were washed with PBS,
counted, and injected intravenously at 10
 
7
 
 cells per animal into ir-
radiated (725 Rad, 24 h in advance) recipients. Both males and
females 5–8 wk of age were used. Diabetes was detected by daily
monitoring for 21 d of glucose levels in urine, using Diastix re-
agent strips (Bayer Corp.).
 
Fluorescent Tracing and Morphometric Analysis.
 
For trafficking
studies, IS-CD8
 
 
 
 and control T cells were incubated at 10
 
7
 
 cells/
ml for 30 min at 37
 
 
 
C in the dark in complete medium contain-
ing 5% FCS and 0.0075 mg/ml of fluorescent dye didodecyl-tet-
ramethylindocarbocyanine perchlorate (DiI; Molecular Probes),
then washed three times with PBS. For analysis of short-term
proliferation and adhesion studies IS-CD8
 
 
 
 cells were stained in
vitro with fluorescent dye carboxyfluorescein diacetate succini-
midyl ester (CFSE; Molecular Probes) as described (12). 10
 
7
 
 of la-
beled IS-CD8
 
 
 
 cells were injected intravenously into irradiated
(725 Rad, 24 h in advance) animals. Mice were killed at time
points indicated, and their spleens, pancreata, lymph nodes, pe-
ripheral blood, and lungs were removed, lymphocytes were iso-
lated as described (5), stained with allophycocyanin-conjugated
anti-CD8 (53–6.7) antibody (BD Biosciences), and subjected to
FACS
 
®
 
 analysis. Alternatively, organs were fixed in 0.1 M perio-
date-lysine-paraformaldehyde phosphate buffer, sucrose-satu-
rated, and freeze-molded in OCT compound (Sakura Finetek
Inc.). 7-
 
 
 
m-thick cryostat sections of the entire pancreas were
obtained at 60 
 
 
 
m intervals using a Leica CM1900 cryotom
(Leica). Distribution of DiI-labeled CD8
 
 
 
 cells within the islets
was examined using a fluorescent microscope DMLB (Leica). At
least 100 islets per mouse were examined. Cells were counted
within areas relevant to a given islet (see Fig. 1 for representative
image). Each IS-CD8
 
 
 
 cell was ascribed a specific position: either
at the islet entrance (attached to the capillary wall or located in
the isthmus) or inside the islet.
 
Monoclonal Antibodies and FACS
 
®
 
 Analysis.
 
IS-CD8
 
 
 
 cells
were stained in FACS
 
®
 
 buffer (PBS with 1% FCS and 0.1%
NaN
 
3
 
) with anti-CD11a (2D7), anti-CD18 (C71/16), anti-CD31
(MEC13.3), anti-CD44 (1M7.8.1), anti-CD49d (SG31), anti-
CD62L (MEL-14), anti-CD54 (3.E.2), anti-CD103 (2-E7), anti-
LPAM (DATK-32), mAbs (all BD Biosciences); anti-CD29 mAb
(Chemicon Corp.); anti CD49a (Ha 31/8), anti-CD49b (Ha
1/29) mAbs (Biogen Corp.), and anti–E-cadherin (DECMA-1)
mAb (Sigma-Aldrich). This was followed by staining with appro-
priate FITC- or PE-conjugated secondary antibodies (BD Bio-
sciences). Staining with mouse P-selectin-human Ig fusion pro-
tein (BD Biosciences), and mouse ELC-human Ig fusion protein
(gift of Dr. Ulrich von Andrian, Harvard University, Boston,
MA) was followed by goat anti–human Ig-FITC conjugate
(Sigma-Aldrich). IS-C8
 
 
 
 cells were counterstained with PE or
FITC-conjugated anti-CD8 antibody (Sigma-Aldrich). For geno-
typing of H2
 
k/g7
 
 and H2
 
d/g7
 
 segregants of (C3D2)F1xNOD ori-
gin, mouse PBL were stained with FITC-conjugated anti-H2-K
 
k
 
(36.7.5 or 16–3-1) antibodies (BD Biosciences), in combination
with Red-316-conjugated anti-CD4 (BRL) and PE-conjugated
anti-CD8 antibodies (BD Biosciences). Multi-color analysis was
performed using a FACScan™ flow cytometer and using
CELLQuest™ software (Becton Dickinson).
 
Chromium Release Cytotoxicity Assay.
 
Pancreatic islets or
monolayers of cultured aortal endothelial cells were dispersed into
single-cell suspension by incubation in cell-dissociation buffer
(Sigma-Aldrich), labeled with 100 
 
 
 
Ci of Na
 
2
51
 
CrO
 
4
 
 (ICN Phar-
maceuticals) in 200 
 
 
 
l of complete Click’s medium containing 5%
FCS for 2 h at 37
 
 
 
C, washed three times, and cocultured for 8–12 h
in 96-well plates (10
 
4
 
 targets per well in 200 
 
 
 
l of Click’s me-
dium with 5% FCS) with effector IS-CD8
 
 
 
 cells at different effec-
tor-to-target ratios with different concentrations of InsB
 
15–23
 
 pep-
tide. To confirm the cytotoxic potential of IS-CD8
 
 
 
 cells, labeled
P815 mastocytoma (H2
 
d
 
) cells were loaded with different concen-
trations of InsB
 
15–23
 
 peptide and used as targets in the 4 h cytotox-
icity assay. Specific cytotoxicity was based on the measurement of
 
51
 
Cr release in 100 
 
 
 
l aliquots of cell-free supernatant using a
gamma-counter (Wallac) and calculated using the formula: specific
cytotoxicity (%) 
 
 
 
 ([experimental release 
 
  
 
spontaneous release]/
[maximum release 
 
 
 
 spontaneous release]) 
 
 
 
 100%.
 
Immunohistochemistry.
 
Cryostat sections of fresh-frozen pan-
creas were cut 7-
 
 
 
m thick, immediately fixed in cold acetone
(Fisher Scientific; 3 min at –20
 
 
 
C), air-dried for 2 h, and stained
for 1 h at room temperature with mAbs against adhesion mole-
cules: anti-VCAM-1 (429), anti-MadCAM (MECA-367),
anti-PECAM (MEC 13.3), anti-CD34 (RAM34), anti-PNAd
(MECA-79), anti-ICAM-1 (3.E.2), anti- ICAM-2 (3C4); endo-
thelial cells marker: anti-CD105 (MJ7/18) (all BD Biosciences),
and polyclonal antibodies against the 
 
 
 
 cell marker Glut-2
(whole anti-Glut-2 rabbit serum, gift from Dr. Bernard Thorens,
University of Lausanne, Switzerland), and polyclonal goat anti-
mouse antibodies against chemokine anti-SLC (R&D Systems).T
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Staining with corresponding FITC- or Rhodamine-labeled sec-
ondary antibodies (Jackson ImmunoResearch Laboratories) fol-
lowed. After the final wash, slides were mounted in Vectashield
mounting medium (Vector Laboratories) and examined using
fluorescent microscopy.
 
Pancreatic Islet Cultures and Cytotoxicity Assays.
 
Pancreatic is-
lets were cultured in Click’s medium supplemented with 10%
FCS and 0.1 mg/ml of Endothelial Cell Growth Supplement
(ICN Pharmaceuticals) in 8-well chambered glass slides (Nunc),
precoated with 2% gelatin (Sigma-Aldrich). 7 d later, IS-CD8
 
 
 
cells were added to the half of the chambers containing islet cul-
tures for 12 h, while the other half was left unaltered. Live cultures
were stained for 1 h at room temperature with affinity-purified
rabbit anti–Glut-2 polyclonal antibodies and rat anti-CD105
(MJ7/18) or anti-CD31 (MEC13.3) mAbs followed by two
5-min washes and addition of corresponding secondary antibod-
ies. After the final wash, chambers were detached, and slides were
mounted in Vectashield medium and immediately examined.
CD105
 
 
 
 or CD31
 
 
 
 cells in each well were counted, and the fol-
lowing formula was used to measure specific cytotoxicity: specific
cytotoxicity (%) 
 
 
 
 (mean # of CD105
 
 
 
 cells in intact wells 
 
 
 
mean # of CD105
 
 
 
 cells in the wells exposed to IS-CD8
 
 
 
):
([mean # of CD105
 
 
 
 cells in intact chambers]) 
 
 
 
 100%. Mixed
NOD and B6-GFP islet organ cultures were exposed to IS-CD8
 
 
 
cells or left intact, stained for CD105, and after the final wash
were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 20 min
at 
 
 
 
4 C. Slides mounted in Vectashield medium were examined
under the fluorescent microscope. The ratio of GFP CD105 
cells to CD105  cells was determined for each well. At least 200
cells/well of 3–4 wells per experiment were counted.
Fibronectin Binding Assay. IS-CD8  cells harvested four days
after IL-2 stimulation were used for the soluble fibronectin (FBN)
binding assay performed as described (15). Briefly, 5   106 IS-
CD8  cells were preincubated with 5  g/ml of biotinylated 145–
2C11 (anti-CD3) antibody (BD Biosciences) in Click’s medium
containing 5% FBS for 30 min on ice, washed two times in PBS
buffer, and cross-linked with 5  g/ml of avidin-PE conjugate
(BD Biosciences) in the presence of 100  g/ml of FITC-labeled
FBN or FITC-labeled BSA (Sigma-Aldrich) as a control. FITC-
labeling was performed using the Fluorotag FITC conjugation kit
(Sigma-Aldrich) according to the manufacturer’s instructions. Pu-
rified R1–2 (anti–VLA-4) and M17/4 (anti–LFA-1) antibodies
were added at a concentration of 5  g/ml during the addition of
soluble FBN. Upon addition of labeled FBN-FITC or BSA-
FITC, cells were incubated for 30 min on ice followed by transfer
to a 37 C water bath for 10 min. After two washes with ice-cold
FACS® buffer, cells were analyzed immediately by FACS®.
Primary Vascular Endothelium Cell Culture. Isolation and cul-
ture of vascular endothelium from mouse aorta was performed as
described (16). Briefly, neutralized collagen extracellular matrix
was aliquoted into 24-well plates, allowed to gel at 37 C for 60
min, and equilibrated overnight with complete endothelial cell
medium consisting of complete Click’s medium with 20% FCS,
and 50  g/ml of Endothelial Cell Growth Supplement (Becton
Dickinson). The segments of thoracic aorta from adult NOD
mice were placed endothelial-side down onto the collagen gel. 36
h later 1 ml of complete endothelial cell medium was carefully
added. After 3–5 d, the collagen gel was digested with a 0.3% col-
lagenase H (Sigma-Aldrich) solution and the released cells were
transferred to a T25 tissue culture flask. After reaching conflu-
ence, cells were detached by incubation with cell-dissociation
buffer (Sigma-Aldrich), and split at a 1:3 ratio. Passage 2 to 5 cells
were used for the experiments.
Parallel Plate Flow Chamber and Adhesion Assay. Aortal endo-
thelial cells were plated on 35-mm Costar tissue culture dishes
and allowed to reach confluence. The cells were then treated for
2–3 h with 100  M of InsB15–23 or LLO91–99 peptides in complete
endothelial cell medium. In some experiments anti-Kd (SF
1–1.1) blocking mAbs were added for 20 min before the adhe-
sion assay. The adhesion of IS-CD8  cells under shear stress was
examined with a parallel plate flow chamber obtained from Gly-
cotech following the manufacturer’s instructions and as described
previously (17–19). A flow chamber with a 5-mm-wide gasket
was used. Negative flow pressure was generated and controlled
with an automated syringe pump (Braintree Scientific). IS-CD8 
cells were labeled with CFSE as described above, pretreated in
some experiments with 100 ng/ml of mouse recombinant SLC
(R&D Systems) in Click’s medium for 30 min, and injected at a
concentration of 3   106/ml into the flow chamber. After IS-
CD8  cells were allowed to settle on the plate for the indicated
length of time, the flow rate was increased stepwise every 10 s in
increments of 1.28 ml/min ( 4 dynes/cm2 shear stress) to a max-
imum of 7.7 ml/min (corresponding to  24 dynes/cm2). Lym-
phocyte adhesion was visualized with a Leica inverted fluorescent
microscope and recorded using a Spot-RT digital camera (Diag-
nostic Instruments). Images were converted into digital movies
and analyzed using Metamorph software (Universal Imaging
Corp.). Labeled IS-CD8  cells were counted in frames separated
by equal time intervals from the start of the stress. Adhesion of
cells in each frame was determined as a fraction (%) of the initial
number of cells in the frame preceding the start of flow.
Treatment with Pertussis Toxin. For treatment with Pertussis
toxin (PTx), IS-CD8  cells were harvested, resuspended at 107
cells/ml in complete medium containing 100 ng/ml of PTx
(Sigma-Aldrich), and incubated for 2 h at 37 C. The final 30 min
of incubation were combined with DiI-labeling. Treated cells
were washed and injected into irradiated hosts or cultured under
standard conditions in vitro.
Treatment with Anti-SLC. Irradiated (725 Rad, 24 h in ad-
vance) NOD mice were injected intravenously with 30–50  g of
polyclonal anti-SLC antibody (R&D Systems) or control goat Ig.
DiI-labeled IS-CD8  cells were injected 1 h later. Mice were
killed at times indicated, and morphometric analysis of the pan-
creata was performed.
Pancreatic Corrosion Casting. Corrosion casts of pancreatic mi-
crocapillaries were produced as described (20) with modifica-
tions. Briefly, mice were killed by overdose of anesthesia, per-
fused with 250 ml of warm PBS containing 1 U/ml of heparin
and green food dye to ensure perfusion quality. Resin was pre-
pared before injection by mixing Mercox, methyl methacrylate
(Polysciences Inc.), and Catalyst at a 4:1:0.2 ratio and injected
with a 30 g needle into the abdominal aorta near the branching of
the upper mesenteric artery. Mercox and Catalyst were purchased
as a kit from Ladd Research Industries. In 5–10 min, pancreata
with polymerized resin were excised, placed in 54 C water for
1–2 h, incubated overnight with 2 mg/ml of pronase (Roche Di-
agnostics) in 50 mM Tris buffer with 20 mM EDTA, 2% SDS,
pH 8.0, washed in H2O, and immersed in 50% KOH solution at
50 C for 24 h. Casts washed with hot running water were dried,
mounted, gold-coated, and examined by SEM.
Online Supplemental Material. Supplemental Fig. S1 showing
that irradiation has no effect on pancreatic homing of IS-CD8 
cells, supplemental Fig. S2 illustrating that homing to the islets
depends upon T cell specificity, supplemental Fig. S3 showing
that accumulation of IS-CD8  cells in the islets is not due to local
proliferation, and supplemental Fig. S4 showing that activation ofT
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IS-CD8  cells through the TCR leads to activation of inte-
grins  are available at http://www.jem.org/cgi/content/full/
jem.20021378/DC1.
Results
Homing of the IS-CD8  Cells to the Pancreatic Islets Does
Not Require Preexistent Inflammation. To address the ques-
tion of whether the homing of IS-CD8  cells into the pan-
creas requires an ongoing inflammation that induces ex-
pression of adhesion molecules and chemokines, we
performed adoptive transfer experiments. IS-CD8  cells
were injected intravenously into NOD/LtJ, BALB/cJ, and
DBA/2J mice and caused rapid diabetes in all strains tested
(Fig. 1 A). All of these mice express MHC class I Kd mole-
cules. Strains that do not express Kd were previously shown
to be resistant (6). We also performed a direct in vivo trac-
ing experiment. For that, IS-CD8  cells were labeled with
a fluorescent dye, DiI, and injected intravenously into
NOD and DBA/2J recipients. 24 h later the pancreata
were fixed and cryostat sections analyzed. Labeled IS-
CD8  cells were readily detected in the islets in both
NOD and DBA/2J mice (Fig. 1 B). In addition, we in-
jected labeled IS-CD8  cells into NOD.Rag1-KO mice,
which lack T and B lymphocytes, and are inflammation-
free. Fig. 1 C shows that IS-CD8  cells could be easily
found in the islets of NOD.Rag1-KO mice.
As we routinely irradiate recipient mice to create a
“niche” for donor cells and to minimize host response to
incompatible donor cells, we tested whether irradiation af-
fects homing to the islets. There was no difference in hom-
ing of IS-CD8  cells into the islets of irradiated and nonir-
radiated NOD.Rag1-KO mice (online supplemental Fig.
S1). Hence, irradiation was not responsible for the “activa-
tion” of endothelium in inflammation-free animals. Thus,
IS-CD8  cells can home to the islets that do not have prior
inflammation and their homing is quite tissue-specific. IS-
CD8  cells express cellular adhesion molecules CD31,
CD44, and CD54; integrins CD11a ( L chain), CD103
( IEL chain), CD49b ( 2 chain), CD49d and CD29 ( 4
Figure 1. Preexistent inflammation is not
required for IS-CD8  cells homing into
pancreatic islets. (A) IS CD8  cells cause
rapid diabetes in mice that express H2-Kd.
Recipient mice were irradiated with 725
Rad and injected with 107 IS-CD8  T cells.
Diabetes was detected by measuring urine
glucose, and confirmed by blood glucose
measurement. (B) Cryosections of pancreata
from NOD and DBA/2J mice injected with
107 DiI-labeled IS-CD8  cells and killed
24 h later. Islet boundaries are marked by a
dotted line. For morphometric analysis la-
beled cells were counted within an area rel-
evant to a given islet (white rectangle). Cells
within islet boundaries were considered to
be “inside,” cells within rectangle but out-
side of islet boundaries were considered to
be “at the entrance.” (C) IS-CD8  cells can
be easily detected in disaggregated pancre-
atic islets from NOD.Rag1-KO mice 24 h
after injection. T cells were labeled with
CFSE. Numbers indicate percentage of
CFSE  CD8  cells in total live cell popula-
tions within scatter gates containing (but
not limited to) the lymphocyte fraction. (D)
Pancreatic islets of NOD. 2m-KO mice
contain no CFSE  IS-CD8  cells 24 h after
injection. Gates as in C.T
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integrin VLA-4), and CD18 ( 2 integrin LFA-1), as well as
P-selectin ligands (not shown). l-selectin, LPAM, E-cad-
herin, and CD49a molecules were absent from IS-CD8 
cells’ surface (not shown). Low levels of ligands for LFA-1
are known to be constitutively expressed by the endothe-
lium of the islets, while the VLA-4 ligand VCAM-1 is in-
ducible (21–23). Thus, integrins and/or P-selectin ligands
are likely to contribute to the early stages of adhesion to the
pancreatic endothelium engaging constitutively expressed
counterparts present in the absence of inflammation.
Homing to the Islets Requires MHC Class I Expression.
As inflammation was not necessary for the initial steps in
pancreatic homing of IS-CD8  T cells, we tested whether
homing of IS-CD8  T cells could be antigen-driven.
For  that, NOD mice lacking MHC class I molecules
(NOD. 2m-KO mice), were injected with labeled IS-
CD8  cells and their pancreata examined (Fig. 1 D). There
was hardly any significant number of IS-CD8  cells in the
isolated islets 24 h after injection. To show that pancreas
was the only organ in the NOD. 2m-KO mice where IS-
CD8  cells refused to home, compared with NOD mice,
we analyzed cryostat sections of several tissues from NOD
and NOD. 2m-KO mice injected with DiI-labeled IS-
CD8  cells (Fig. 2). This systematic analysis of tissue distri-
bution of the IS-CD8  cells revealed that the difference
between the two recipients was obvious only in the pan-
creatic islets. Was MHC class I–dependent homing indeed
peptide specific?  Evidence for peptide specificity came
from the analysis of mice that expressed the H2k MHC
haplotype along with expression of the H2-Kd molecule.
Such mice are resistant to IS-CD8  cell-induced diabetes
(see online supplemental Table S1), and resistance was
linked to the lack of specific homing of activated IS-CD8 
cells to the islets in H-2k/g7 animals (Fig. 3 A, a): 24 h after
IS-CD8  cell injection H-2k-positive islets contained  16-
fold fewer labeled cells. Further analysis revealed that the
presence of H2k (or closely linked genes) caused the lack of
presentation of InsB15–23 peptide by Kd molecules. This was
shown by testing of the direct recognition of islet   cells
from H2k/d animals by IS-CD8  cells. Islets from C3D2
Figure 2. MHC class I expression affects homing of IS-CD8  cells to the pancreatic islets, but not to other tissues. Cryostat sections of the indicated
organs isolated 24 h after injection of the DiI-labeled IS-CD8  cells. The red color of the tissue is autofluorescence, DiI stained cells are bright yellow.
Most typical examples of sections are shown. The red frame highlights the difference in homing of the labeled cells to the pancreata of NOD and
NOD. 2m-KO mice.T
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(H2k/d) and control B6D2 (H2b/d) mice were dispersed to
single cell suspensions, labeled with 51Cr, and exposed to
IS-CD8  cells.
  cells from mice positive for H2k were resistant to lysis
(Fig. 3 A, b). However, when the InsB15–23 synthetic pep-
tide was added exogenously, lysis was restored (Fig. 3 A, b),
arguing that the block of lysis was neither due to a general
malfunction of Kd molecules, nor to activation of inhibi-
tory receptors on the CTL. The only reasonable explana-
tion for this finding was that products of genes linked to
H2k were prohibiting the formation of functional Kd/
insB15–23 complexes. Thus, the absence of specific antigenic
complexes, and not the general deficiency in MHC class I
(found in NOD. 2m-KO mice), is critical for the lack of
specific homing of IS-CD8  cells to the pancreas.
To confirm that homing to the islets is not a property of
any activated T cell, we also used T cell clones with differ-
ent specificities. DiI-labeled cells of LPa/2R-1 CD8  clone
(13) reactive to Db complex with a peptide from minor his-
tocompatibility antigen H3aa which is widely expressed in
NOD mice were not detectable in the pancreatic islets 2 or
24 h after injection, while the numbers of the LPa/2R-1
cells in the other tissues such as lungs (online supplemental
Fig. S2) were comparable to the numbers of IS-CD8 
cells. Similarly, two other CD8  T cell lines, Db-restricted
H3ab-specific clone B/L (recognizing H3ab allele not ex-
pressed in NOD mice; reference 13; not shown), and
L12.3, Kd–restricted anti-listeriolysin clone (14) migrated
to spleens but not to pancreata of NOD recipients (online
supplemental Fig. S2).
Thus, homing of IS-CD8  cells appears to be both anti-
gen-driven and pancreas-specific. However, IS-CD8  cells
need to cross the endothelial cell layer in order to penetrate
the islets. Taking in consideration that homing also occurs
in the absence of local inflammation, we hypothesized that
endothelial cells present MHC–insulin peptide complexes
to T cells, stimulating their adhesion and penetration into
the islets.
Endothelial Cells from Pancreatic Islets Can Be Recognized by
IS-CD8  Cells In Vivo and In Vitro. To test this hypothe-
sis, we further used NOD. 2m–KO mice as recipients of
DiI-labeled IS-CD8  T cells. Their islets were analyzed at
different time points after injection of IS-CD8  cells (Fig.
3 B). Morphometric analysis allows not only a calculation
of the numbers of infiltrating cells, but also reveals their lo-
calization. The numbers of cells accumulated in different
locations reflect the process of T cell homing. As expected,
the numbers of IS-CD8  cells found in the MHC class
I–deficient islets 24 h after injection were extremely small
compared with those found in the islets of MHC-sufficient
NOD mice. Most importantly, very few T cells were
found to be located at the islet vascular isthmus in MHC
class I–negative NOD mice. If their firm adhesion to the
endothelium was MHC class I independent, we would be
Figure 3. Lack o f specific
MHC class I–peptide complexes
affects homing of IS-CD8 
cells. (A) In the presence of H2k
IS-CD8  cells fail to migrate
into islets (a), or kill islet cells (b).
Both properties can be explained
by the lack of Kd-InsB15–23 com-
plexes. (a) Labeled IS-CD8 
cells were injected into
(C3D2XNOD)F1 mice with ei-
ther H2k/g7 (filled bar) or H2d/g7
(clear bar) MHC alleles. Mor-
phometric analysis of the pancre-
ata was performed 24 h later.
Combined data from two exper-
iments represent mean numbers
of IS-CD8  cells per islet
(within white rectangle in Fig.
1) SE. n, number of mice per
group.  *, difference vs. H2d/g7
mice is significant by Student’s
paired t test (P   0.05). (b) IS-
CD8  cells kill islet cells isolated
from H2b/d B6D2 mice, but not
the islet cells from H2k/d C3D2
mice. Addition of exogenous
InsB15–23 peptide (done at a 50:1
effector-to-target ratio only) re-
stored killing of H2k/d islet cells
to the level of killing of H2b/d is-
lets. Data from a representative
experiment. (B) Morphometric
analysis of pancreata from  2m-deficient, and -sufficient NOD mice for the presence of labeled IS-CD8  cells at different times after injection. Each cell
was ascribed its position as shown in Fig. 1. n, number of mice of each genotype analyzed at each time point. Data show mean numbers of IS-CD8  cells
per islet detected at the indicated location   SE. *, difference between NOD and NOD. 2m-KO is significant by Student’s t test (P   0.01).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
649 Savinov et al.
able to detect IS-CD8  cells in the vascular isthmus of
NOD. 2m–KO mice, which was not the case. It was pos-
sible, however, that accumulation of IS-CD8  cells in the
islets of NOD mice was exclusively due to a secondary ac-
tivation of endothelium caused by recognition of Kd–insu-
lin peptide complexes in the islets themselves, which
would be impossible in  2m-negative mice. That would
lead to fast “passing-through” of IS-CD8  cells in  2m-
negative islets, and 24 h after injection we would be simply
unable to detect that. However, we were able to detect IS-
CD8  cell accumulation at the entrance rather early (1.5 h
after injection) in NOD mice (Fig. 3 B). Importantly, such
accumulation preceded penetration into the islets. In con-
trast, at no time points could we detect accumulation of IS-
CD8  cells in  2m-negative mice at the islet isthmus or in-
side the islets. These results argue that not only the islet
penetration, but also the adhesion to endothelium, were
abolished by elimination of MHC class I expression. More-
over, accumulation with time of IS-CD8  cells at the
isthmi and inside the islets is not due to local proliferation,
but due to additional recruitment from the bloodstream. 24 h
after injection we found no explicit proliferation of CFSE-
labeled IS-CD8  cells isolated from the islets compared
with IS-CD8  cells isolated from the spleens (online sup-
plemental Fig. S3).
To further support the hypothesis that endothelial cells
can function as APC for IS-CD8  cells, we proceeded to
show that endothelial cells in the pancreatic islets could be
directly recognized by IS-CD8  cells. For that we used is-
let organ cultures. On day 7 of the islet organ culture IS-
CD8  cells were added for 12 h. Immediately after that,
the live cultures were stained with antibodies against a  
cell marker, glucose transporter 2 (Glut-2), and an endo-
thelial marker CD105 (endoglin). Glut-2  and CD105 
cells are clearly nonoverlapping populations in islets of the
intact pancreas or in isolated islets in culture (Fig. 4 A). The
numbers of remaining CD105  cells were counted in islet
cultures exposed or not to IS-CD8  cells. In the cultures of
MHC class I–sufficient NOD or B6.NOD-H2g7 (congenic
strain with H2g7 on B6 background) islets the majority of
the Glut-2  cells were destroyed by IS-CD8  cells. Impor-
tantly, most of the CD105  cells were also destroyed. In
NOD. 2m-KO or B6 islet cultures, on the other hand,
Glut-2  and CD105  cells remained intact, indicating that
the killing of CD105  cells (or CD31  cells in some exper-
iments, not shown) was specific and that B6 genetic back-
ground did not matter for susceptibility to specific killing
(Fig. 4 B, a). Moreover, when NOD endothelial cells were
isolated from nonislet source (aorta) and cultured without
insulin-producing    cells, they were insensitive to IS-
CD8  cells cytotoxicity unless exogenous Ins-B15–23 pep-
tide was added (Fig. 4 B, b). However, the possibility
existed that in NOD islet cultures the recognition by IS-
CD8  cells of their primary targets, the antigen-expressing
  cells, led to secretion of cytotoxic cytokines that killed
endothelial (CD105 ) cells nonspecifically. This would not
have occurred in NOD. 2m-KO or B6 islet cultures, as
MHC class I Kd molecules were not present, or in aortal
endothelial cells. To address this caveat, we cultured a mix-
ture of the islets isolated from NOD and B6-GFP mice,
which ubiquitously express green fluorescent protein
(GFP). These mixed islet cultures were exposed to IS-
CD8  cells and stained with anti-CD105 (Fig. 4 C). The
ratio of cells double-expressing GFP and CD105  to the
total number of CD105  cells was measured by direct cell
counting using fluorescent microscopy. The results re-
vealed that NOD-derived GFP CD105  cells were elimi-
nated, while B6-derived GFP CD105  cells remained in-
tact (Fig. 4 C, c). That suggested that CD105 cells must
express the cognate MHC–peptide complex to be de-
stroyed by IS-CD8  cells.
How is the insulin peptide-Kd complex acquired by en-
dothelium? High local concentration of insulin suggests
that secreted protein may be taken up by endothelial cells
and then cleaved to peptides. If that was true,   cells that
make insulin (and insulin peptide-Kd complexes) but have
impaired insulin secretion, would be susceptible to lysis by
CTL but inaccessible for them because the endothelium is
not cross-presenting the antigen. Support for this hypothe-
sis came from the analysis of IS-CD8  cells trafficking
into the islets of NOD.B6Akita/  mice homozygous for
H2g7 and heterozygous for the dominant mutation desig-
nated Ins2Akita in the insulin 2 gene. This point mutation
(Cys96Tyr) affects processing and secretion of both insulin
1 and insulin 2 proteins in a dominant fashion, so that insu-
lin release is greatly diminished and diabetes develops very
early (24, 25). Labeled IS-CD8  cells were found to home
significantly less efficiently (tested at 2 and 24 h after injec-
tion) to the islets of mice bearing the Ins2Akita mutation than
to the islets of their wild-type littermates (Fig. 5 A). Very
importantly,   cells isolated from mutant mice were sensi-
tive to IS-CD8  cells in vitro (Fig. 5 B). Because of the
substantial depletion of   cells from the pancreatic islets of
Ins2Akita mice (24), the level of cytotoxicity for mutant islets
was lower than that observed for wild-type islets (Fig. 5 B).
Nevertheless, IS-CD8  cells were clearly capable of direct
recognition of the islet cells of NOD.B6Akita/  mice. Thus,
IS-CD8  cells were able to recognize   cells but stopped
short of adhesion to the islet vasculature. This argues that
secretion of insulin, the protein donor of antigenic peptide,
is essential for presentation of the Kd-Ins15–23 complex by
endothelial cells, and suggests that generation of MHC–
insulin peptide complexes depends on degradation of insu-
lin by endothelial cells.
Chemokine Receptors Are Involved in IS-CD8  Cell Hom-
ing. Although signaling through TCR leads to activation
of integrins on the T cell surface (references 26–28; we
found that it was also true for the particular IS-CD8  cell
clone that we were using, see online supplemental Fig. S4),
it is unlikely that this mechanism alone could account for
the strength of interactions with the endothelium needed
for complete arrest of T cell rolling. Integrin activation may
be also triggered through G-protein–coupled chemokine
receptors (29–32). As homing of lymphocytes usually de-T
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650 MHC-dependent Homing of Diabetogenic T Cells
pends heavily on the recognition of tissue-specific chemo-
kines (33), we sought to address the question of whether
chemokine receptors are involved in trafficking of IS-
CD8  cells to the pancreatic islets. We started with treat-
ment of IS-CD8  cells with PTx, a potent inhibitor of
G-protein–coupled receptor signaling. IS-CD8  cells treated
with PTx or PBS were stained with DiI and injected into
NOD mice. The cells treated with PTx did not lose their
viability and responded normally to InsB15–23 peptide stim-
ulation 24 h after treatment (not shown). The presence of
IS-CD8  cells in the pancreatic islets was assessed 24 h after
injection by analysis of cryostat sections (Fig. 6 A). PTx-
treated IS-CD8  cells were practically absent from the is-
lets, suggesting the possibility that chemokine receptors
were involved in the homing of IS-CD8  cells. The multi-
tude of chemokines and their receptors complicates the task
of identifying of a specific pair. However, when we exam-
ined lymphoid organs of NOD mice injected with PTx-
Figure 4. Endothelial cells from islet organ cultures are killed by IS-CD8  cells in antigen-specific fashion. (A)   cells and endothelial cells can clearly
be distinguished both in the native islets (a) and in in vitro culture (b) by staining with anti-Glut-2 (green) and anti-CD105 (red). (c) Nomarsky (DIC)
image of islet culture (same field as in b). 10  and 20  lenses were used in a and b, c, respectively. (B) CD105  cells in the islet cultures are destroyed
by IS-CD8  cells in vitro. (a) Specific killing of endothelial cells in islet organ cultures from NOD, NOD. 2m-KO, B6.NOD-H2g7, and B6 mice by
IS-CD8  cells added for 12 h on day 7 of islet culture was calculated using the formula: Specific cytotoxicity (%)   [(mean # of CD105  cells in intact
wells   mean # of CD105  cells in the wells exposed to IS-CD8  cells)/mean # of CD105  cells in intact chambers]   100%. CD105  cells (3–4 par-
allel wells per experiment) were counted using a fluorescent microscope. Combined data from three independent experiments. *, difference vs. NOD is
significant (P   0.005); **, difference vs. B6.NOD-H2g7 is significant (P   0.005) by Student’s paired t test. (b) Endothelial cells isolated from NOD
aorta were killed by IS-CD8  cells in 51Cr release assay only when exogenous Ins B15–23 peptide (0.1  M) was added. Addition of 0.1  M of control Kd-
binding LLO91–99 peptide had no effect. Data from a representative experiment. (C) IS-CD8  cells do not kill bystander Kd-negative CD105  cells in the
presence of Kd-sufficient targets. Islets from NOD and B6-GFP mice were mixed, cultured in vitro for 7 d, then exposed to IS-CD8 cells for 12 h or left
intact, stained for CD105, fixed, and analyzed by fluorescent microscopy. Representative images of NOD and B6-GFP mixed islet cultures before (a),
and after exposure to IS-CD8 cells (b). 40  objective was used. (c) Formal estimation of the results shown in a and b. Specific loss of GFP-negative,
CD105 , Kd-sufficient NOD cells was determined by the proportion (%) of GFP  CD105  cells among total CD105  cells in mixed NOD and B6-GFP
islet cultures left intact or exposed to IS-CD8  cells. Combined data from three independent experiments. *, difference is significant (P   0.05) by Stu-
dent’s t test.T
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651 Savinov et al.
treated IS-CD8  cells, we detected a clue to the identity of
the chemokine that could assist in trafficking to the pancre-
atic islets. In our experiments, the presence of labeled IS-
CD8  cells in the spleen always serves as an internal control
for the quality of the transfer. When NOD mice were in-
jected with IS-CD8  cells treated with PTx, we found that
the distribution of these cells in the spleen was different
from the distribution of untreated cells: PTx-treated cells
avoided T cell zones (Fig. 6 B, a and b). Homing of T cells
to the T cell zones of the secondary lymphoid organs is
controlled by a pair of chemokines, CCL21 (also known as
6Ckine, Exodus-2, SLC) and CCL19 (MIP-3 , Exodus-3,
ELC; 34, 35). SLC expression in the T cell zones of spleen
by immunofluorescence is shown in Fig. 6 B, c. As both
SLC (CCL21) and ELC (CCL19) chemokines have been
shown to trigger  2 integrin affinity and mobility changes
promoting LFA-1–mediated lymphocyte adhesion (36, 37),
we asked whether these chemokines were involved in the
homing of IS-CD8  cells to the pancreatic islets.
First, we blocked SLC function by treating mice with
anti-SLC antibodies in vivo, followed by the transfer of la-
beled IS-CD8  T cells. Cryostat sections of the pancreata
from mice injected with anti-SLC were compared with
those from mice injected with normal goat Ig by counting
labeled cells per islet (Fig. 6 C). Anti-SLC antibodies had a
profound effect on the IS-CD8  T cells’ ability to adhere
to the islet endothelium (2 and 24 h after injection) and to
penetrate the islets (24 h after injection). Clearly, the hom-
ing of IS-CD8  T cells decreases if SLC is neutralized.
The antibodies did not cause any loss of injected cells as
their numbers in peripheral blood and spleens were similar
(not shown).
Second, we stained cryostat sections of the pancreata
from different mice with anti-chemokine antibodies. We
found that SLC was expressed in the isthmus of the islets
(Fig. 6 D). Most of the SLC-positive cells are localized to
lymphatics and lack endothelial markers (not shown), but
SLC is easily and highly diffusible: intradermal injection of
SLC affected homing of T cells to the regional lymph
nodes (38), and ectopic overexpression in   cells (39, 40)
recruited lymphocytes to the islets. Importantly, SLC ex-
pression was found in the islets of diabetes-prone NOD
mice, as well as in the islets of mice with no spontaneous
diabetes and no preexistent inflammation, i.e., DBA/2J
(H2d) and C3D2 (H2kxd) mice. Of the latter two strains,
DBA/2J mice were sensitive to the transfer of IS-CD8  T
cells, while C3D2 mice were resistant.
Two important conclusions can be drawn from these
findings: (a) chemokines, namely SLC, play a critical role in
IS-CD8  T cells homing to the islets of Langerhans, but
(b), SLC expression does not correlate with inflammation
and is not sufficient per se for the homing of IS-CD8  T
cells, and is likely to act in concert with recognition of an
islet-specific peptide presented by endothelial cells.
Triggering of TCR and Chemokine Receptors of IS-CD8 
Cells Cooperate in Strengthening T Cell Adhesion to the Endo-
thelium. To test whether activation of IS-CD8  cells
through their TCR would lead to a detectable activation
of integrins on their surface, we stimulated IS-CD8  cells
with anti-CD3 antibodies and immediately stained them
with FITC-labeled fibronectin. Anti-CD3 stimulation led
to increased binding of FBN-FITC to IS-CD8  cells (on-
line supplemental Fig. S4 A). FBN binds to  4 integrins
with high affinity when they are activated (41–43). This
binding, along with the low binding seen in IS-CD8  cells
before anti-CD3 exposure, was completely blocked by an-
tibodies to VLA-4 integrin (online supplemental Fig. S4
B), but not by antibodies to LFA-1, which does not bind
FBN. Thus, activation of T cells through their antigen-
specific receptors led to the activation of integrins. These
results clearly support the idea that recognition of specific
MHC-peptide complexes may participate in the homing
of IS-CD8  cells, enhancing adhesion between T cells and
endothelium. We applied an “adhesion under shear stress”
approach to gain further support for our hypothesis that
MHC–peptide recognition is important for T cell adhesion
to endothelial cells and, hence, for homing. For that, the
monolayers of aortal endothelium from NOD mice were
used as targets for adherence of IS-CD8  cells in the Gly-
cotech flow chamber. T cells were allowed to adhere to
the endothelial cells, and then the flow of tissue culture
medium with several increments of pressure was initiated.
It became clear that precultivation of endothelial monolay-
ers with the InsB15–23 peptide (but not without the peptide
Figure 5. Secretion of insulin is a prerequisite
for homing of IS-CD8  cells. Labeled IS-CD8 
cells were injected into NOD.B6Akita/  or
NOD.B6 /  wild-type littermates. All mice
were homozygous for H2g7. (A) Morphometric
analysis of pancreata was performed at indicated
times after injection. Data represent mean num-
bers of IS-CD8  cells per islet SE. n, number
of mice per group. Difference between groups
is significant, as *P   0.04, **P   0.03 by Stu-
dent’s t test. (B) Pancreatic islet cells isolated
from NOD.B6Akita/  and NOD.B6 /  were
sensitive to direct lysis by IS-CD8  effector
cells, showing that the cognate MHC–peptide
complex was produced by   cells and expressed
on their surface. B6Akita/  - Kd-negative control.
Data from a representative experiment.T
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652 MHC-dependent Homing of Diabetogenic T Cells
or with an irrelevant Kd-binding peptide) led to increased
adhesion of the T cells (Fig. 7 A). However, to achieve ad-
hesion significantly different from that in the no-peptide
control, T cells had to be allowed to stay in contact with
endothelial cells for 300 s before the start of flow. The ad-
hesion, however, became stronger when T cells were pre-
treated with SLC before the test: the time necessary for ad-
hesion was reduced to 90 s, the fraction of adherent cells
was larger, and more of them stayed attached longer than
T cells that were not exposed to SLC. This adhesion was
specific, as it occurred only in the presence of specific pep-
tide, and it was possible to suppress it by addition of anti-
bodies against H-2Kd molecules to the monolayers before
the test (Fig. 7 B). The pretreatment with SLC also in-
creased the baseline adhesion in the absence of specific
peptide, but the cooperation of peptide and SLC made the
specific adhesion stronger.
Thus, cooperation of multiple mechanisms regulating T
cell adhesion to the endothelium is required for their spe-
cific homing. The two mechanisms described above are
both complementary and essential for this process.
Discussion
Homing of activated T cells to sites where they are most
needed (where pathogens are present) or where they are
most harmful (in autoimmunity) are likely to be controlled
by similar mechanisms. Using T cells that recognize an an-
tigen uniquely produced by a specialized tissue, the islets of
Langerhans in the pancreas, we were able to analyze the in-
Figure 6. Chemokines play an important role in IS-CD8  cells homing to the islets. (A) Treatment of IS-CD8  cells with PTx which blocks signaling
through chemokine receptors, abolishes their homing to the islets. IS-CD8  cells treated with PTx in vitro were labeled and injected into NOD mice. In
24 h untreated cells penetrated into islets (a), while cells treated with PTx did not (b). (c) Morphometric analysis shows quantitative measurement of
homing of PTx-treated vs. nontreated IS-CD8  cells. n, number of mice per group. *P   0.003 by Student’s t test. (B) Unlike untreated IS-CD8  cells
(a), PTx-treated IS-CD8  cells lost ability to home to T cell zones in the spleen (b), suggesting that SLC may be involved. (c) SLC (CCL-21) expression
in the splenic T cell zones revealed by staining with specific anti-SLC antibodies (green fluorescence). Serves as positive control to D. (C) SLC is a pri-
mary chemokine responsible for IS-CD8  cells homing to the islets. Pretreatment of recipient mice with anti-SLC serum abolished IS-CD8  cells hom-
ing to the islets. Data represent mean number of IS-CD8  cells per islet   SE detected at indicated times after injection. n, number of mice per group.
*P   0.002, **P   0.001 by Student’s t test. (D) SLC expression was found in the isthmus regions of the islets in NOD, DBA/2J, and C3D2 mice, indi-
cating that SLC is not the sole factor determining homing of IS-CD8  cells. Negative control included treatment with normal goat serum and secondary
labeled antibodies. Islet boundaries are marked by a dotted red line.T
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teractions required for the islet-specific homing of CD8  T
cells. Homing is a multistep process that allows T cells to
cross into tissues through the endothelium of microcapillary
vessels. Each of these steps (initial tethering, slow rolling,
activation-dependent arrest, and diapedesis) is controlled by
different interactions of surface molecules and multiple sig-
naling pathways triggered by such interactions (30, 33).
Some aspects of T cell trafficking to the pancreas, such as
the role of integrins and their ligands, have been addressed
previously. It has been shown that LFA-1/ICAM-1, VLA-
1/VCAM-1, and  4 integrin/MadCAM interactions are
important for the homing of diabetogenic T cells to the
pancreas (21, 44, 45). It is widely believed (and rightly so)
that inflammation that induces many adhesion molecules
facilitates the homing of T cells. However, when we intro-
duced IS-CD8  T cells into mice with no preexistent in-
flammation, the mice rapidly developed diabetes, and la-
beled IS-CD8  cells were found in their islets (Fig. 1). This
was taken as evidence that no inducible molecules are re-
quired for the initiation of homing of IS-CD8  to the is-
lets. Interestingly, IS-CD8  cells were never found in sali-
vary glands of NOD mice (Fig. 2), although NOD mice
typically develop inflammation of salivary glands. Thus, in-
flammation by itself cannot determine the homing of IS-
CD8  T cells.
To explain the inflammation-independent organ-specific
homing of IS-CD8  cells, we put forward a hypothesis that
endothelium can cross-present the antigen and thus partici-
pate in T cell adhesion in an antigen-specific fashion. We
found experimental evidence to support this hypothesis:
first, homing to the pancreas but not to other organs de-
pended on expression of MHC class I and of the specific
peptide (Figs. 2 and 3); second, IS-CD8  cells up-regulated
itegrin avidity upon stimulation of their TCR (online sup-
plemental Fig. S4) and demonstrated adhesion to endothe-
lial cells under shear stress in the presence of specific pep-
tide (Fig. 7); third, endothelial cells from pancreatic islets
could be directly recognized in in vitro cytotoxicity assay
(Fig. 4). This direct recognition did not occur due to the
presence of insulin in the tissue culture medium, as aortal
endothelium cultivated in the same medium was not recog-
nized by IS-CD8  cells (Fig. 4 B, b). Thus, pancreatic en-
dothelial cells have a necessary machinery to acquire insulin
from   cells and produce the cognate peptide. The mode of
acquisition of the Kd-InsB15–23 complexes by endothelial
cells is not yet established. However, the observation that
IS-CD8  cells have a reduced ability to home into the islets
of NOD.B6Akita/  mice (Fig. 5) suggested that the peptide
was generated by endothelial cells from secreted insulin
rather than acquired as a peptide or an MHC–peptide com-
plex produced by   cells. It is possible, however, that in
NOD.B6Akita/  mice other properties of endothelium are
affected by insulin deficiency reducing T cell adhesion.
The need in secreted insulin for peptide presentation
suggests that the peptide is generated by endosomal rather
than proteosomal degradation. This scenario is not unprec-
edented, as evidence in favor of alternatives to the conven-
tional MHC class I peptide processing and presentation
pathway is accumulating (46–48). These studies have
shown that MHC class I molecules could be found in classi-
cal MHC class II compartments, and that the TAP-inde-
pendent and proteosome-independent pathways can lead to
presentation of peptides by MHC class I. The fact that en-
dothelial cells can serve as APC has been established previ-
ously (10, 11, 49). Hepatic endothelial cells were found ca-
pable of presenting complexes of MHC class I molecules
with peptides derived from an injected foreign soluble pro-
tein (50). However, cross-presentation of peptides derived
from endogenously produced protein has not been de-
scribed. Local concentration of insulin is very high amount-
ing to 7% of total islet protein (51). Insulin produced locally
in such high concentrations may be broken down into pep-
tides by endothelial cells. We do not know yet whether en-
dothelium is destroyed by IS-CD8  cells in vivo, or it is ac-
tivated to facilitate T cell adhesion and diapedesis. This is an
important issue and a matter of future studies. Our own
Figure 7. Expression of spe-
cific MHC–peptide complex in-
duces adhesion of IS-CD8  cells
to endothelium and works in
concert with SLC. (A) After
300 s of adhesion to aortal endo-
thelial cell monolayers pretreated
or not with InsB15–23 peptide, IS-
CD8  cells were exposed to
shear stress of the flow of tissue
culture medium implemented in
4 dyne/cm2 increments with 10 s
intervals.  *, difference in per-
centage of adherent IS-CD8 
cells is significant for each pair of
points of equal shear stress ap-
plied (P    0.05 by Student’s t
test). (B) IS-CD8  cells were
pretreated with 100 ng/ml of
SLC and allowed to adhere to endothelial monolayers expressing Kd complexes with InsB15–23 or LLO91–99 for 90 s. In parallel experiments anti-Kd mono-
clonal antibodies were added to monolayers expressing Kd complexes with InsB15–23. *, difference in percentage of adherent IS-CD8  cells is significant
for each pair of points of equal shear stress applied (P   0.05 by Student’s t test). n, number of measurements.T
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data (Fig. 3 B) showed that secondary activation of endo-
thelium is occurring with time, leading to an increase of the
numbers of IS-CD8  cells found in the isthmus.
Firm adhesion of IS-CD8  cells is also controlled by
G-protein–coupled chemokine receptors. We have found that
SLC is the chemokine responsible for homing of IS-CD8 
T cells (Fig. 6 C). Its expression was detected in the pan-
creas by immunostaining (Fig. 6 D), but it was present not
only in NOD mice, which may have an ongoing inflamma-
tion, but also in DBA/2J mice (with no preexistent inflam-
mation) and in C3D2 mice, in which IS-CD8  T cells do
not home to the islets. It is very likely that at advanced
stages of diabetes development, SLC expression in the pan-
creas of NOD mice increases enhancing the infiltration by
T cells (52, 53). However, our data showed that constitu-
tive presence of SLC in the pancreas in diabetes-free mice is
required for IS-CD8  homing, but by itself is not sufficient
for successful homing. Similarly, in the in vitro adhesion
under shear stress assay, SLC treatment of T cells slightly in-
creased their adhesion to the endothelium without the cog-
nate peptide. Nevertheless, the best adhesion was achieved
when MHC/peptide complexes and SLC worked in con-
cert (Fig. 7 B). A model describing additive effects of anti-
gen recognition and activation of the chemokine receptor
CCR7 on the surface of IS-CD8  cells is shown in Fig. 8.
CCR7 expression by IS-CD8  cells was confirmed by
staining with ELC-Ig fusion protein, and by real-time RT-
PCR (not shown). Thus, SLC-triggered integrin activation
may be aided by TCR-mediated activation of integrins (26,
36, 41). We found that TCR-mediated integrin activation
was also a property of IS-CD8  cells, as the avidity of VLA-4
toward fibronectin increased after stimulation with anti-
TCR antibody (online supplemental Fig. S4). Other inte-
grins (e.g., LFA-1) are likely to be activated in IS-CD8 
cells in a similar fashion after TCR engagement. Homing
specificity is maintained by fulfillment of both requirements
(presence of appropriate peptide and an appropriate chemo-
kine receptor): a CCR7-positive T cell clone LPa/2R-1
with different specificity did not show any significant accu-
mulation in the pancreatic islets 2 or 24 h after injection
(online supplemental Fig. S2). The results show that pan-
creatic endothelium is not randomly attracting any T cells
that are capable of sensing SLC, but only those that have
appropriate specificity (Fig. 8).
Our study suggests that endothelial cells may play a more
prominent role in the trafficking of activated T cells than is
currently appreciated, providing antigen-driven specificity
of homing. It remains to be established how general this
principle is. While insulin is a secreted protein, it is unclear
whether similar mechanisms may work for nonsecreted an-
tigens. However, two recent studies (49, 54) suggest that
endothelium (at least in transplantation models) can cross-
present nonsecreted antigens. It is difficult to underestimate
the significance of such a mechanism for the development
of autoimmune diabetes. Because IS-CD8  cells were
found to be a predominant fraction of the islet-infiltrating
cell population in NOD mice very early in the pathogene-
sis of diabetes (5) they may provide assistance to other T
cells in the penetration of islets through activation of the
local endothelium. The presence of SLC and activating sig-
nals from IS-CD8  cells may lead to the initial accumula-
tion of lymphocytes at the vascular entrance (known as
Figure 8. A model showing how endothelial cells in the pancreas contribute to islet-specific homing of diabetogenic T cells. (A) The vast microcap-
illary network within the islet of Langerhans revealed by corrosion casting technique suggests an immense surface of interaction between insulin-produc-
ing cells and endothelial cells. (B) T cell invasion of the islets requires firm adhesion to endothelial cells. This can be achieved by activation of integrins on
the T cell via two independent, but cooperating pathways: via chemokine receptors sensing chemokines deposited on the endothelial cell surface (non-
specific component), and via the TCR (specific component). The latter requires presentation of pancreatic antigens such as insulin by endothelial cells.
Although it is yet unclear how the cross-presentation occurs, the intact secretion of insulin by   cells is needed.T
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periinsulitis), which later develops into accumulation of
lymphocytes within the islets (insulitis) and damage to the
insulin-producing cells (diabetes).
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